Page last updated: 2024-10-22

alprenolol and Experimental Leukemia

alprenolol has been researched along with Experimental Leukemia in 2 studies

Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wingard, LB1
Simantov, R1
Sachs, L1

Reviews

1 review available for alprenolol and Experimental Leukemia

ArticleYear
Immobilized drugs and enzymes in biochemical pharmacology. Perspectives and critique.
    Biochemical pharmacology, 1983, Sep-15, Volume: 32, Issue:18

    Topics: Alprenolol; Animals; Blood Glucose; Cell Membrane; Diabetes Mellitus, Type 1; Enzymes, Immobilized;

1983

Other Studies

1 other study available for alprenolol and Experimental Leukemia

ArticleYear
Differential desensitization of functional adrenergic receptors in normal and malignant myeloid cells: relationship to receptor-mediated hormone cytotoxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 1978, Volume: 75, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Alprenolol; Animals; Cell Differentiation; Cell Line; D

1978